Anonymous
Guest
Anonymous
Guest
2q15 tracking $ABBV Vpak ~7% global market share based on revenues!!!
BE INSPIRED.... WERE GETTING CLOSER TO THE 51% TARGET !!!!
I am ashamed to be a part of the HCV Franchise!! Wow do we SUCK!!
2q15 tracking $ABBV Vpak ~7% global market share based on revenues!!!
BE INSPIRED.... WERE GETTING CLOSER TO THE 51% TARGET !!!!
The Crain's article is intersting. Not sure how you're a biochemist without a degree and working as such. If you have no degree and work in a lab you're usually a lab assisitant or a bottle washer.
Symphony VPak numbers for w/e 6/5; TRx@ 871 & NRx@ 495
TRx is -9% compared to its high 955 reported w/e 5/22
NRx is -8% compared to its high 536 reported w/e 4/3
Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/5; TRx@ 11,437 & NRx@ 5,057
BE INSPIRED.... WERE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....
Symphony VPak numbers for w/e 6/5; TRx@ 871 & NRx@ 495
TRx is -9% compared to its high 955 reported w/e 5/22
NRx is -8% compared to its high 536 reported w/e 4/3
Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/5; TRx@ 11,437 & NRx@ 5,057
BE INSPIRED.... WERE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....
Symphony VPak numbers for w/e 6/5; TRx@ 871 & NRx@ 495
TRx is -9% compared to its high 955 reported w/e 5/22
NRx is -8% compared to its high 536 reported w/e 4/3
Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/5; TRx@ 11,437 & NRx@ 5,057
BE INSPIRED.... WERE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....
Who's Melissa ?
What is the talk I am hearing of a re-launch campaign coming up after July 4? I heard this from a vendor who swab test for Hep C (among other dangerous infections).
I'm glad Mr Schlict addressed this with the Managers at the NSM. Well done.
Who is the original poster? By here is a handsome reward for credible leads.
We all know it was the KC DM!
We all know it was the KC DM!